Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial-Reference-Cited by-同舟云学术

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Published:2013-08 Issue:9894 Volume:382 Page:780-789
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

McInnes Iain B,Kavanaugh Arthur,Gottlieb Alice B,Puig Lluís,Rahman Proton,Ritchlin Christopher,Brodmerkel Carrie,Li Shu,Wang Yuhua,Mendelsohn Alan M,Doyle Mittie K

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Psoriatic arthritis: epidemiology, clinical features, course, and outcome;Gladman;Ann Rheum Dis,2005

2. Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis;Leonard;Mayo Clin Proc,1978

3. Prevalence of joint disease in patients with psoriasis: implications for therapy;Zachariae;Am J Clin Dermatol,2003

4. Mortality studies in psoriatic arthritis: results from a single outpatient center. II: prognostic indicators for death;Gladman;Arthritis Rheum,1998

5. Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts;Khraishi;Clin Rheumatol,2011

Cited by 693 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol;BMJ Open;2024-09

2. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

3. Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy;Rheumatology and Therapy;2024-08-12

4. Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison;Rheumatology and Therapy;2024-08-09

5. One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn’s Disease: The K-STAR Study;Inflammatory Bowel Diseases;2024-08-03